| Methods |
NON‐ CONTACT LASER.
Tissue effect: coagulation. Subjects blinded: No |
| Participants |
N=151 men, >50 yrs old.
Country/Region: UK
Mean age: 68 yrs (range 52‐84)
Race: not stated
Not available to follow‐up: 29 (17%). |
| Interventions |
1. VLAP (n=76): Urolase fiber ‐
Nd‐YAG laser ‐ settings; 60 watts, 60 spd x 4, 4 to 9 minutes per session (mps). 2. TURP (n=75).
Catheter protocol: at MD discretion.
Routine antibiotics (preop): at MD discretion.
Mean average of follow‐up: 12 months |
| Outcomes |
American Urological Association (AUA) symptom score; peak urine flow (PUF); residual volume (RV); total voided volume (TVV); hospital length of stay; rehospitalization/re‐operation; adverse events. |
| Notes |
Inclusion criteria: candidates for surgical treatment of Bladder outflow obstruction (BOO) secondary to Benign prostatic hyperplasia (BPH). |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Low risk |
A ‐ Adequate |
